Science Corp. (@science.xyz) announced that they have raised $230M, which will enable them to "to fully see through the commercialization of our brain-computer interface (BCI) retinal implant, PRIMA, as well as advance our other core pipeline programs into the clinic." science.xyz/news/series-c/
science.xyzScience Closes $230 Million Series C to Fund Commercialization of PRIMA BCI Retinal Implant and Expansion of Clinical Trials | Science CorporationScience Corporation is a clinical-stage medical technology company.
2 reposts3 likes